TNGX - Tango Therapeutics GAAP EPS of -$0.33 misses by $0.01 revenue of $6.92M beats by $1.28M November, 10 2022 09:23 AM Tango Therapeutics Inc. Tango Therapeutics press release ( NASDAQ: TNGX ): Q3 GAAP EPS of -$0.33 misses by $0.01 . Revenue of $6.92M (+1.9% Y/Y) beats by $1.28M . For further details see: Tango Therapeutics GAAP EPS of -$0.33 misses by $0.01, revenue of $6.92M beats by $1.28M